MoneyWorks4Me

Cadila Healthcare informs about press release

13 Aug 2021 Evaluate

Cadila Healthcare has informed that it enclosed a copy of press release dated August 13, 2021 titled ‘Zydus Cadila receives final approval from USFDA for Mesalamine Extended-Release Capsules’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1242.00
Cipla 1331.00
Lupin 1953.75
Zydus Lifesciences 1113.00
View more..